Oaktree Capital Group Holdings GP, LLC - Nov 25, 2024 Form SCHEDULE 13G Schedule Report for BioXcel Therapeutics, Inc. (BTAI)

Filing Manager
Oaktree Capital Group Holdings GP, LLC
Reporting Manager
Oaktree Capital Group Holdings GP, LLC
Security
BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
BTAI
Shares outstanding
52.4M shares
Disclosed Ownership
2.72M shares
Ownership
5.2%
Form type
SCHEDULE 13G
Date filed
12/18/2024, 08:19 PM
Date of event
Nov 25, 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Oaktree Fund Advisors, LLC 1.6% 823K 0 823K /s/ Henry Orren Henry Orren / Authorized Signatory
OAKTREE CAPITAL MANAGEMENT LP 3.6% 1.9M 0 1.9M /s/ Henry Orren Henry Orren / Authorized Signatory
Oaktree Capital Group Holdings GP, LLC 5.2% 2.72M 0 2.72M /s/ Henry Orren Henry Orren / Authorized Signatory
Oaktree Capital Holdings, LLC 5.2% 2.72M 0 2.72M /s/ Henry Orren Henry Orren / Authorized Signatory